Partial miscibility in the solid state is an undesireable property of chiral substances with regard to separation by crystallisation. Nevertheless, the incorporation of molecules of the counter enantiomer into the lattice of either the pure enantiomer or the racemic compound is known for various substances, e.g. [1, 2]. Partial solid solutions at the enantiomer side limit the attainable purity of this enantiomer (fig. 1) and miscibility in the vicinity of the racemic compound makes an enantiomeric enrichment more difficult (fig. 1a). While from the thermodynamic point of view chiral resolutions for systems showing miscibility in the solid state are not feasible, the kinetics of solid-solid transformations must not be neglected. The temporal...
Abstract By far the most systems of enantiomers exhibit compound formation. Crystallization is one p...
Solution-phase racemization drives the evolution of single chirality in the solid phase by the “chir...
With the movement by pharmaceutical companies to develop single enantiomers instead of racemic mixtu...
Partial miscibility in the solid state is an undesireable property of chiral substances with regard ...
The appearance of mixed crystals of organic compounds is frequently discussed in recent literature a...
The appearance of mixed crystals of organic compounds is frequently discussed in recent literature a...
The appearance of mixed crystals of organic compounds is frequently discussed in recent literature a...
Objectives of this project are: (1) Understanding of the factors that control the formation of enan...
Solution-phase racemization drives the evolution of single chirality in the solid phase by the "chir...
Objectives of this project are: (1) Understanding of the factors that control the formation of enan...
Solution-phase racemization drives the evolution of single chirality in the solid phase by the “chir...
In this work a systematic study of the potential of chiral solvents in enantioselective crystallizat...
Abstract By far the most systems of enantiomers exhibit compound formation. Crystallization is one p...
The large discrepancies in the physiological impact of a pair of molecules, that can be discriminate...
The large discrepancies in the physiological impact of a pair of molecules, that can be discriminate...
Abstract By far the most systems of enantiomers exhibit compound formation. Crystallization is one p...
Solution-phase racemization drives the evolution of single chirality in the solid phase by the “chir...
With the movement by pharmaceutical companies to develop single enantiomers instead of racemic mixtu...
Partial miscibility in the solid state is an undesireable property of chiral substances with regard ...
The appearance of mixed crystals of organic compounds is frequently discussed in recent literature a...
The appearance of mixed crystals of organic compounds is frequently discussed in recent literature a...
The appearance of mixed crystals of organic compounds is frequently discussed in recent literature a...
Objectives of this project are: (1) Understanding of the factors that control the formation of enan...
Solution-phase racemization drives the evolution of single chirality in the solid phase by the "chir...
Objectives of this project are: (1) Understanding of the factors that control the formation of enan...
Solution-phase racemization drives the evolution of single chirality in the solid phase by the “chir...
In this work a systematic study of the potential of chiral solvents in enantioselective crystallizat...
Abstract By far the most systems of enantiomers exhibit compound formation. Crystallization is one p...
The large discrepancies in the physiological impact of a pair of molecules, that can be discriminate...
The large discrepancies in the physiological impact of a pair of molecules, that can be discriminate...
Abstract By far the most systems of enantiomers exhibit compound formation. Crystallization is one p...
Solution-phase racemization drives the evolution of single chirality in the solid phase by the “chir...
With the movement by pharmaceutical companies to develop single enantiomers instead of racemic mixtu...